Instil Bio, Inc.
TIL
$15.30
-$1.18-7.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.49M | 10.71M | 10.71M | 12.42M | 14.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.38M | 11.27M | 13.63M | 19.68M | 16.24M |
| Operating Income | -15.38M | -11.27M | -13.63M | -19.68M | -16.24M |
| Income Before Tax | -11.90M | -23.02M | -14.92M | -24.30M | -12.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.90M | -23.02M | -14.92M | -24.30M | -12.93M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.90M | -23.02M | -14.92M | -24.30M | -12.93M |
| EBIT | -15.38M | -11.27M | -13.63M | -19.68M | -16.24M |
| EBITDA | -14.64M | -10.37M | -12.65M | -18.69M | -15.20M |
| EPS Basic | -1.82 | -3.54 | -2.29 | -3.74 | -1.99 |
| Normalized Basic EPS | -1.48 | -1.02 | -1.38 | -1.92 | -1.55 |
| EPS Diluted | -1.82 | -3.54 | -2.29 | -3.74 | -1.99 |
| Normalized Diluted EPS | -1.48 | -1.02 | -1.38 | -1.92 | -1.55 |
| Average Basic Shares Outstanding | 6.53M | 6.50M | 6.50M | 6.50M | 6.50M |
| Average Diluted Shares Outstanding | 6.53M | 6.50M | 6.50M | 6.50M | 6.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |